149 related articles for article (PubMed ID: 36703095)
41. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
[TBL] [Abstract][Full Text] [Related]
42. Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging.
Takeuchi H; Greep NC; Hoon DS; Giuliano AE; Hansen NM; Umetani N; Singer FR
J Clin Endocrinol Metab; 2007 May; 92(5):1785-90. PubMed ID: 17299072
[TBL] [Abstract][Full Text] [Related]
43. Flow cytometric DNA analysis of benign hyperfunctioning parathyroid glands: significant difference in the S phase fraction and proliferative index between adenomas and hyperplasias.
Berczi C; Bocsi J; Balázs G; Lukács G
Pathology; 2002 Oct; 34(5):442-5. PubMed ID: 12408343
[TBL] [Abstract][Full Text] [Related]
44. Ectopic parathyroid adenoma--the hidden culprit.
Muthukrishnan J; Verma A; Modi KD; Kumaresan K; Jha S
J Assoc Physicians India; 2007 Jul; 55():515-8. PubMed ID: 17907504
[TBL] [Abstract][Full Text] [Related]
45. The clinical significance and anatomic distribution of parathyroid double adenomas.
Bergson EJ; Heller KS
J Am Coll Surg; 2004 Feb; 198(2):185-9. PubMed ID: 14759773
[TBL] [Abstract][Full Text] [Related]
46. Location of abnormal parathyroid glands: lessons from 810 parathyroidectomies.
LoPinto M; Rubio GA; Khan ZF; Vaghaiwalla TM; Farra JC; Lew JI
J Surg Res; 2017 Jan; 207():22-26. PubMed ID: 27979480
[TBL] [Abstract][Full Text] [Related]
47. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia.
van Vonderen IK; Kooistra HS; Peeters ME; Rijnberk A; van den Ingh TS
J Comp Pathol; 2003 Jul; 129(1):61-9. PubMed ID: 12859909
[TBL] [Abstract][Full Text] [Related]
48. Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues.
Ikeda K; Arnold A; Mangin M; Kinder B; Vydelingum NA; Brennan MF; Broadus AE
J Clin Endocrinol Metab; 1989 Dec; 69(6):1240-8. PubMed ID: 2573615
[TBL] [Abstract][Full Text] [Related]
49. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
50. Primary hyperparathyroidism: a current perspective.
DeLellis RA; Mazzaglia P; Mangray S
Arch Pathol Lab Med; 2008 Aug; 132(8):1251-62. PubMed ID: 18684024
[TBL] [Abstract][Full Text] [Related]
51. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
52. Apoptosis in Primary Hyperparathyroidism.
Segiet OA; Mielańczyk Ł; Piecuch A; Michalski M; Tyczyński S; Brzozowa-Zasada M; Deska M; Wojnicz R
J Invest Surg; 2018 Aug; 31(4):328-332. PubMed ID: 28362510
[TBL] [Abstract][Full Text] [Related]
53. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
Marx SJ; Lourenço DM
Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
[TBL] [Abstract][Full Text] [Related]
54. Water Clear Cell Adenoma of the Parathyroid Gland: A Forgotten Cause of Primary Hyperparathyroidism.
El Hussein S; Poppiti R
Int J Surg Pathol; 2017 Aug; 25(5):384-388. PubMed ID: 28382826
[TBL] [Abstract][Full Text] [Related]
55. Methylation status of the CpG islands in vitamin D and calcium-sensing receptor gene promoters does not explain the reduced gene expressions in parathyroid adenomas.
Varshney S; Bhadada SK; Sachdeva N; Arya AK; Saikia UN; Behera A; Rao SD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1631-5. PubMed ID: 23913941
[TBL] [Abstract][Full Text] [Related]
56. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis.
Sudhaker Rao D; Han ZH; Phillips ER; Palnitkar S; Parfitt AM
Clin Endocrinol (Oxf); 2000 Sep; 53(3):373-81. PubMed ID: 10971456
[TBL] [Abstract][Full Text] [Related]
57. [The use of flow cytometry in the study of parathyroid hyperplasia and adenomas].
Mangili F; Sassi I; Schiaffino E; Zogno C; Cantaboni A; Schmid C
Pathologica; 1992; 84(1092):459-65. PubMed ID: 1491887
[TBL] [Abstract][Full Text] [Related]
58. Overview of the 2022 WHO Classification of Parathyroid Tumors.
Erickson LA; Mete O; Juhlin CC; Perren A; Gill AJ
Endocr Pathol; 2022 Mar; 33(1):64-89. PubMed ID: 35175514
[TBL] [Abstract][Full Text] [Related]
59. Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma.
Árvai K; Nagy K; Barti-Juhász H; Peták I; Krenács T; Micsik T; Végső G; Perner F; Szende B
Pathol Oncol Res; 2012 Jul; 18(3):607-14. PubMed ID: 22198862
[TBL] [Abstract][Full Text] [Related]
60. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
